Functional neuroimaging studies of the effects of psychotherapy

Dialogues in Clinical Neuroscience

Volumn 16, Issue 1, 2014, Pages 75-81

  Beauregard, Mario ^a  

^a The University of Arizona   (United States)

Author keywords

Anxiety disorders; Brain; Major depressive disorder; Neuroimaging; Psychotherapy

Indexed keywords

ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; MAJOR DEPRESSION; POSITRON EMISSION TOMOGRAPHY; PSYCHOTHERAPY; BRAIN; PHYSIOLOGY;

BRAIN; FUNCTIONAL NEUROIMAGING; HUMANS; PSYCHOTHERAPY;

EID: 84898846600     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Linden DE. How psychotherapy changes the brain-the contribution of functional neuroimaging. Mol Psychiatry. 2006;11:528-538.
2. Marano G, Traversi G, Nannarelli C, Pitrelli S, Mazza S, Mazza M. Functional neuroimaging: points of intersection between biology and psychotherapy. Clin Ter. 2012;163:e443-456.
3. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry. 2001;58:641-648.
4. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry. 2001;58:631-640.
5. Drevets WC. Functional anatomical abnormalities in limbic and pre-frontal cortical structures in major depression. Prog Brain Res. 2000;126:413-431.
6. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61:34-41.
7. Kennedy SH, Konarski JZ, Segal ZV, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry. 2007;164:778-788.
8. Dichter GS, Felder JN, Smoski MJ. The effects of brief behavioral activation therapy for depression on cognitive control in affective contexts: an fMRI investigation. J Affect Disord. 2010;126:236-244.
9. Buchheim A, Viviani R, Kessler H, et al. Changes in prefrontal-limbic function in major depression after 15 months of long-term psychotherapy. PLoS One. 2012;7:e33745.
10. Ongur D, Ferry AT, Price JL. Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol. 2003;460:425-449.
11. Caspar F. Psychotherapy research and neurobiology: challenge, chance, or enrichment? Psychother Res. 2003;13:1-23.
12. Carmichael ST, Price JL. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol. 1995;363:615-641.
13. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10:206-219.
14. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry. 2002;59:597-604.
15. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception, II: implications for major psychiatric disorders. Biol Psychiatry. 2003;54:515-528.
16. Lane RD, Reiman EM, Ahern GL, Schwartz GE, Davidson RJ. Neuroanatomical correlates of happiness, sadness, and disgust. Am J Psychiatry. 1997;154:926-933.
17. Reiman EM, Lane RD, Ahern GL, et al. Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry. 1997;154:918-925.
18. Teasdale JD, Howard RJ, Cox SG, et al. Functional MRI study of the cognitive generation of affect. Am J Psychiatry. 1999;156:209-215.
19. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry. 2001;50:651-658.
20. Davidson RJ, Irwin W, Anderle MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry. 2003;160:64-75.
21. Fu CH, Williams SC, Cleare AJ, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry. 2004;61:877-889.
22. Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin invest. 2009;119:717-725.
23. Etkin A, Pittenger C, Polan HJ, Kandel ER. Toward a neurobiology of psychotherapy: basic science and clinical applications. J Neuropsychiatry Clin Neurosci. 2005;17:145-158.
24. Ablon JS, Jones EE. Validity of controlled trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 2002:159:775-783.
25. Roffman JL, Marci CD, Glick DM, Dougherty DD, Rauch SL. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med. 2005; 35:1385-1398
26. Schwartz JM, Stoessel PW, Baxter Jr LR, Martin KM, Phelps ME. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:109-113.
27. Schwartz JM, Begley S. The Mind and the Brain: Neuroplasticity and the Power of Mental Force. New York, NY: Harper Collins (Regan Books); 2002.
28. Nyanaponika T. The Vision of Dhamma: Buddhist Writings of Nyanaponika Thera. Seattle, WA: BPS Pariyatti Editions; 2000.
29. Prasko J, Horacek J, Zalesky R, et al. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett. 2004;25:340-348.
30. Sakai Y, Kumano H, Nishikawa M, et al. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitivebehavioral therapy. Neuroimage. 2006;33:218-226.
31. Lindauer RJ, Booij J, Habraken JB, et al. Effects of psychotherapy on regional cerebral blood flow during trauma imagery in patients with post-traumatic stress disorder: a randomized clinical trial. Psychol Med. 2008;38:543-554.
32. Furmark T, Tillfors M, Marteinsdottir I, et al. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry. 2002;59:425-433.
33. Klumpp H, Fitzgerald DA, Phan KL. Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:83-91.
34. Beck AT, Emery G, Greenberg RL. Anxiety Disorders and Phobias: a Cognitive Perspective. New York, NY: Basic Books; 2005.
35. Paquette V, Lévesque J, Mensour B, et al. Change the mind and you change the brain: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage. 2003;18:401-409.
36. Straube T, Glauer M, Dilger S, Mentzel HJ, Miltner WH. Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage. 2006;29:125-135.
37. Schienle A, Schafer A, Hermann A, Rohrmann S, Vaitl D. Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci. 2007;257:486-493.
38. Lehto SM, Tolmunen T, Joensuu M, et al. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:229-237.
39. Wang T, Huang X, Huang P, et al. Early-stage psychotherapy produces elevated frontal white matter integrity in adult majordepressive disorder. PLoS One. 2013;8:e63081.
40. Beaulieu C. The biological basis of diffusion anisotropy. In: Johansen-Berg H, Behrens TEJ, eds. Diffusion MRi: From Quantitative Measurement to in Vivo Neuroanatomy. London, UK: Elsevier; 2009:105-126.
41. Meyer-Lindenberg A, Poline JB, Kohn PD, et al. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry. 2001;158:1809-1817.